Revenue generated by Angong Niuhuang Wan in urban pharmacies in China 2015-2021
In 2021, the sales revenue of Angong Niuhuang Wan, a high-end Chinese patent drug, in urban pharmacies in China is expected to surpass 3.5 billion yuan. Similar to Pien Tze Huang, the drug contains expensive ingredients such as rhino horn and calculus bovis, its recommended retail price increased by almost 500 percent since the early 2000s, fueling speculations and higher demands in the market.
